Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 40MEQ versus POTASSIUM CHLORIDE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 40MEQ versus POTASSIUM CHLORIDE IN PLASTIC CONTAINER.
POTASSIUM CHLORIDE 40MEQ vs POTASSIUM CHLORIDE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium is the major intracellular cation. It is essential for the maintenance of intracellular tonicity, transmission of nerve impulses, contraction of cardiac, skeletal, and smooth muscle, and maintenance of normal renal function. Replacement therapy corrects hypokalemia.
Potassium chloride dissociates to potassium ions, which are essential for maintenance of intracellular tonicity, nerve impulse conduction, muscle contraction, and cardiac function.
40 mEq orally once daily or divided every 6-12 hours; IV infusion at a rate not exceeding 10 mEq/hour with a maximum concentration of 40 mEq/L via peripheral line.
10-20 mEq intravenously over 1 hour, not exceeding 10 mEq/hour or 200 mEq per day; oral dosing for hypokalemia: 20-40 mEq 2-4 times daily.
None Documented
None Documented
Potassium has no defined elimination half-life as it is a major intracellular ion tightly regulated by homeostatic mechanisms; serum levels reflect distribution and renal function. In anephric patients, the effective half-life is extended significantly.
No classical terminal half-life; plasma potassium is rapidly regulated by cellular uptake and renal excretion, with equilibration half-life of ~1-2 hours in normal renal function.
Renal: >90% of potassium is excreted by the kidneys. Approximately 80-90% of an oral dose is eliminated in urine, with the remainder in feces via intestinal secretion.
Primarily renal (90% excreted unchanged in urine); minor fecal elimination (<10%) via unabsorbed potassium.
Category C
Category C
Electrolyte Replenisher
Electrolyte Replenisher